Suppr超能文献

一种功能上占主导地位的线粒体DNA突变。

A functionally dominant mitochondrial DNA mutation.

作者信息

Sacconi Sabrina, Salviati Leonardo, Nishigaki Yutaka, Walker Winsome F, Hernandez-Rosa Evelyn, Trevisson Eva, Delplace Severine, Desnuelle Claude, Shanske Sara, Hirano Michio, Schon Eric A, Bonilla Eduardo, De Vivo Darryl C, DiMauro Salvatore, Davidson Mercy M

机构信息

Féderation des maladies neuromusculaires, CHU de Nice and INSERM U638, Nice, France.

出版信息

Hum Mol Genet. 2008 Jun 15;17(12):1814-20. doi: 10.1093/hmg/ddn073. Epub 2008 Mar 12.

Abstract

Mutations in mitochondrial DNA (mtDNA) tRNA genes can be considered functionally recessive because they result in a clinical or biochemical phenotype only when the percentage of mutant molecules exceeds a critical threshold value, in the range of 70-90%. We report a novel mtDNA mutation that contradicts this rule, since it caused a severe multisystem disorder and respiratory chain (RC) deficiency even at low levels of heteroplasmy. We studied a 13-year-old boy with clinical, radiological and biochemical evidence of a mitochondrial disorder. We detected a novel heteroplasmic C>T mutation at nucleotide 5545 of mtDNA, which was present at unusually low levels (<25%) in affected tissues. The pathogenic threshold for the mutation in cybrids was between 4 and 8%, implying a dominant mechanism of action. The mutation affects the central base of the anticodon triplet of tRNA(Trp) and it may alter the codon specificity of the affected tRNA. These findings introduce the concept of dominance in mitochondrial genetics and pose new diagnostic challenges, because such mutations may easily escape detection. Moreover, similar mutations arising stochastically and accumulating in a minority of mtDNA molecules during the aging process may severely impair RC function in cells.

摘要

线粒体DNA(mtDNA)的tRNA基因突变在功能上可被视为隐性突变,因为只有当突变分子的比例超过临界阈值(70%-90%)时,才会导致临床或生化表型。我们报告了一种与该规则相悖的新型mtDNA突变,因为即使在低水平异质性的情况下,它也会导致严重的多系统疾病和呼吸链(RC)缺陷。我们研究了一名13岁男孩,他有线粒体疾病的临床、放射学和生化证据。我们在mtDNA的5545位核苷酸处检测到一种新型的异质性C>T突变,该突变在受影响组织中的水平异常低(<25%)。在细胞杂交体中,该突变的致病阈值在4%至8%之间,这意味着其作用机制为显性。该突变影响tRNA(Trp)反密码子三联体的中心碱基,可能会改变受影响tRNA的密码子特异性。这些发现引入了线粒体遗传学中的显性概念,并带来了新的诊断挑战,因为此类突变可能很容易逃脱检测。此外,在衰老过程中随机出现并在少数mtDNA分子中积累的类似突变,可能会严重损害细胞中的RC功能。

相似文献

1
A functionally dominant mitochondrial DNA mutation.
Hum Mol Genet. 2008 Jun 15;17(12):1814-20. doi: 10.1093/hmg/ddn073. Epub 2008 Mar 12.
3
A novel mutation in the mitochondrial tRNA for tryptophan causing a late-onset mitochondrial encephalomyopathy.
Acta Neurol Scand. 2010 Feb;121(2):109-13. doi: 10.1111/j.1600-0404.2009.01243.x. Epub 2009 Sep 10.
4
Further pitfalls in the diagnosis of mtDNA mutations: homoplasmic mt-tRNA mutations.
J Med Genet. 2008 Jan;45(1):55-61. doi: 10.1136/jmg.2007.051185.
6
Multisystem mitochondrial diseases due to mutations in mtDNA-encoded subunits of complex I.
BMC Pediatr. 2020 Jan 29;20(1):41. doi: 10.1186/s12887-020-1912-x.
8
Mitochondrial myopathy associated with a novel 5522G>A mutation in the mitochondrial tRNA(Trp) gene.
Eur J Hum Genet. 2013 Aug;21(8):871-5. doi: 10.1038/ejhg.2012.272. Epub 2012 Dec 12.
9
PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring.
Hum Reprod Update. 2012 Jul;18(4):341-9. doi: 10.1093/humupd/dms008. Epub 2012 Mar 28.
10
A novel point mutation in the mitochondrial tRNA(Trp) gene produces a neurogastrointestinal syndrome.
Eur J Hum Genet. 2004 Jun;12(6):509-12. doi: 10.1038/sj.ejhg.5201185.

引用本文的文献

1
Implications of mtDNA in human health and diseases.
BioTechnologia (Pozn). 2025 Jun 30;106(2):209-222. doi: 10.5114/bta/204532. eCollection 2025.
2
Overview of neuroimaging in primary mitochondrial disorders.
Pediatr Radiol. 2025 Apr;55(4):765-791. doi: 10.1007/s00247-025-06172-y. Epub 2025 Feb 12.
3
Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease.
Nat Metab. 2023 Dec;5(12):2169-2183. doi: 10.1038/s42255-023-00932-6. Epub 2023 Nov 30.
5
The potential of mitochondrial genome engineering.
Nat Rev Genet. 2022 Apr;23(4):199-214. doi: 10.1038/s41576-021-00432-x. Epub 2021 Dec 2.
6
Mitochondrial Heteroplasmy Shifting as a Potential Biomarker of Cancer Progression.
Int J Mol Sci. 2021 Jul 9;22(14):7369. doi: 10.3390/ijms22147369.
7
Mitochondrial DNA copy number in human disease: the more the better?
FEBS Lett. 2021 Apr;595(8):976-1002. doi: 10.1002/1873-3468.14021. Epub 2020 Dec 25.
9
Ancient mitochondrial DNA pathogenic variants putatively associated with mitochondrial disease.
PLoS One. 2020 Sep 24;15(9):e0233666. doi: 10.1371/journal.pone.0233666. eCollection 2020.
10
DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases.
J Intern Med. 2020 Jun;287(6):685-697. doi: 10.1111/joim.13055. Epub 2020 Apr 27.

本文引用的文献

1
Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease.
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7127-32. doi: 10.1073/pnas.0500563102. Epub 2005 May 3.
2
Mitochondrial encephalomyopathies: an update.
Neuromuscul Disord. 2005 Apr;15(4):276-86. doi: 10.1016/j.nmd.2004.12.008.
3
Mutation screening in patients with isolated cytochrome c oxidase deficiency.
Pediatr Res. 2003 Feb;53(2):224-30. doi: 10.1203/01.PDR.0000048100.91730.6A.
4
Mitochondrial threshold effects.
Biochem J. 2003 Mar 15;370(Pt 3):751-62. doi: 10.1042/BJ20021594.
5
Mitochondrial DNA depletion and dGK gene mutations.
Ann Neurol. 2002 Sep;52(3):311-7. doi: 10.1002/ana.10284.
9
A tRNA suppressor mutation in human mitochondria.
Nat Genet. 1998 Apr;18(4):350-3. doi: 10.1038/ng0498-350.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验